Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2001Antimicrobial Agents and ChemotherapyOpen Access

Potentiation of Inhibition of Wild-Type and Mutant Human Immunodeficiency Virus Type 1 Reverse Transcriptases by Combinations of Nonnucleoside Inhibitors andd- andl-(β)-Dideoxynucleoside Triphosphate Analogs

View Full Paper
Ask AI
Bookmark
Share

Authors

GMGiovanni MagaIstituto di Genetica MolecolareUHUlrich HübscherUniversity of ZurichMPMassimo PregnolatoUniversity of Pavia

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Maga et al. (2001) studied this question.

synapsesocial.com/papers/6a70f2f078a11c550e0afa7fhttps://doi.org/10.1128/aac.45.4.1192-1200.2001
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Current knowledge of HIV-1 reverse transcriptase mutations selected during nucleoside analogue therapy: the potential to use resistance data to guide clinical decisions1997 · 29 citations
  2. 2Inhibition of human immunodeficiency virus type 1 reverse transcriptase by the 5'-triphosphate beta enantiomers of cytidine analogs1994 · 63 citations
  3. 3L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase1995 · 481 citations
  4. 4Molecular basis for the enantioselectivity of HIV-1 reverse transcriptase: role of the 3'-hydroxyl group of the L-(beta)-ribose in chiral discrimination between D- and L-enantiomers of deoxy- and dideoxy-nucleoside triphosphate analogs1999 · 15 citations
  5. 5Structural Determinants of HIV-1 Reverse Transcriptase Stereoselectivity Towards (β)-L-Deoxy- and Dideoxy-Pyrimidine Nucleoside Triphosphates: Molecular Basis for the Combination of L-Dideoxynucleoside Analogs with Non-nucleoside Inhibitors in Anti HIV Chemotherapy1999 · 3 citations